Navigation Links
Sequel Systems, Inc. Meaningful Use EHR Receives ONC-ATCB 2011/2012 Certification

MELVILLE, N.Y., Nov. 15, 2010 /PRNewswire/ -- Sequel Systems, Inc., a dynamic, service-oriented healthcare technology company, announced today that its Electronic Health Record (EHR), SequelMed® Meaningful Use EHR version 8.0, has been tested and certified under the Drummond Group's Electronic Health Records ONC-ATCB program. The EHR software is 2011/2012 compliant in accordance with the criteria adopted by the Secretary of Health and Human Services.  The certification deems the electronic health record (EHR) software capable of enabling providers to meet the Stage 1 meaningful use measures required to qualify for incentive payments under the American Recovery and Reinvestment Act (ARRA).  



In addition to the monetary incentives, the adoption of EHRs can improve quality of care, advance patient safety, increase customer satisfaction and enhance office efficiency for physician practices. Facilities and practices using a certified EHR may also experience increased profitability through reduced costs and increased revenue.

"Choosing to test with The Drummond Group made sense for Sequel Systems because the organization is an independent leader in testing methodologies and test process management," said Khurshid Mughal, CEO and President of Sequel Systems.  "Given the level of experience The Drummond Group has, it offers a greater level of confidence to our customers and partners that the SequelMed software meets the requirements as set forth by The Office of National Coordinator."

"Drummond Group has more than 10 years of software testing experience in several industries and we are pleased to bring that experience to the HIT marketplace.  It is a privilege to carry out testing and certification in Electronic Health Records for HHS," said Rik Drummond, CEO Drummond Group Inc.

Sequel Systems, Inc. is a leading provider of EHR and practice management software and solutions, serving approximately 12,000 physicians in North America. Meaningful Use Certification of SequelMed's EHR means clients seeking federal incentives will be technologically prepared to do so.

SequelMed Meaningful Use EHR version 8.0 is a comprehensive clinical, financial and administrative solution that empowers physicians to advance the quality and efficiency of care they deliver. The SequelMed family of products includes integrated electronic health records, practice management, clinical and business intelligence, and Patient Portal - a Web-based tool for online patient engagement. Providers can access SequelMed EHR from multiple practice locations, from home, or other remote locations either through a central patient database server, or as a Sequel-hosted solution on a monthly subscription basis.  The software allows for users to easily track the details of a patient's clinical history, share and manage clinical information and combine complex medical practice functions into easy-to-navigate menus. SequelMed v8.0 features centralized financial operations including billing, reporting, task management, and EDI services.CONTACT: Amanda Leitl-Scanlan Sequel Systems, Inc. 631-694-3600 aleitl@sequelmed.comAbout Sequel SystemsSequel Systems, Inc. is a dynamic service-oriented company that develops software to simplify the complex practice and medical records management needs of healthcare providers while maximizing revenue and streamlining operations. Sequel Systems' suite of flexible, easy-to-use and comprehensive SequelMed® solutions includes practice management, electronic medical records, document management, e-prescribing and financial systems scaled to fit the needs of the small, medium and large enterprises. Today, Sequel Systems' solutions are in use by more than 12,000 physicians in all 50 states to provide the best possible care to patients through the use of technology. For more information about Sequel Systems, visit

About Drummond GroupDrummond Group Inc., the trusted software test lab, provides effective and efficient electronic health record (EHR) testing to healthcare information technology vendors. As an Office of the National Coordinator Authorized Testing and Certification Body (ONC-ATCB), Drummond Group works closely with healthcare software vendors to certify EHRs for use by providers that are looking to qualify for incentive funds under the American Recovery and Reinvestment Act (ARRA).  Drummond Group is approved to certify both complete and modular EHR for both ambulatory and inpatient.  Leveraging more than a decade's worth of interoperability, conformance testing and certification experience in multiple industries, Drummond Group delivers what's needed in healthcare: highly reliable and readily affordable software testing services. For more information, go to


SOURCE Sequel Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207
2. Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program
3. Sequella Receives American Recovery and Reinvestment Funding Through the NIH
4. Sequella and University of Maryland Restate Exclusive License for Jointly Owned Event Marker System Technology
5. SELECT TRIAL Used Selenomethionine Instead of High-Selenium Yeast, SelenoExcell(R) - Previous Research has Shown SelenoExcell(R) Supplementation to Reduce Lung, Colon and Prostate Cancers by as Much as 63%, Says Cypress Systems, Inc.
6. Guided Delivery Systems, Inc. Successfully Treats First Patient with Mitral Regurgitation
7. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
8. Delcath Systems, Inc. Completes Phase III Study Enrollment
9. Delcath Systems, Inc. to Present at the 12th Annual Needham Growth Stock Conference
10. Delcath Systems, Inc. Prices $30.6 Million Stock Offering
11. Millar Instruments and Transonic Systems, Suppliers of Gold Standard Pressure and Flow Products, Enter Into Mutual Distribution Agreement
Post Your Comments:
(Date:6/23/2016)... announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... ... ... Astellas is a pharmaceutical ...
(Date:6/23/2016)... , June 23, 2016 The vast majority ... outpatient dialysis facility.  Treatments are usually 3 times a ... per visit, including travel time, equipment preparation and wait ... but especially grueling for patients who are elderly and ... skilled nursing and rehabilitation centers for some duration of ...
(Date:6/23/2016)... YORK , June 23, 2016 ... waters, but it continues to present great opportunities to ... companies for today: Intrexon Corp. (NYSE: XON ... Arena Pharmaceuticals Inc. (NASDAQ: ARNA ), and ... more about these stocks and receive your complimentary trade ...
Breaking Medicine Technology:
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
Breaking Medicine News(10 mins):